Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance.
- NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_assertion description "[Although patients who were found to have LOI of IGF2 were more likely to have advanced stage gastric tumors (P?=?0.04), no statistically significant differences in survival were found based on imprinting status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance.
- NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_assertion evidence source_evidence_literature NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance.
- NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_assertion SIO_000772 21268128 NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance.
- NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_assertion wasDerivedFrom befree-20140225 NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance.
- NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_assertion wasGeneratedBy ECO_0000203 NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP530755.RAbk7wmRvWUfN1-bUDhFfgPki_Pw1DyJeptYgZ2wOJ5zc130_provenance.